REGN vs SEM · P/E 14, rev $14.34B vs P/E 15, rev $1.31B
Regeneron Pharmaceuticals Inc (REGN) versus Select Medical Holdings (SEM) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Select Medical Holdings (SEM) is a medical care facilities company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SEM revenue for 2024-12-31 was $1.31B. Net income was $3.8M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
Not investment advice. Open the REGN and SEM stock pages for the full models.
Not investment advice.